Literature DB >> 12537738

HIV epidemiology in Morocco: a nine-year survey (1991-1999).

Elharti Elmir1, Safir Nadia, Bennani Ouafae, Mengad Rajae, Siwani Amina, El Aouad Rajae.   

Abstract

The first case of HIV/AIDS in Morocco was notified in 1986. The Moroccan Ministry of Health has set up a system of management of HIV/AIDS cases and surveillance of the epidemic. Between 1991 and 1999, we studied 12,981 sera from patients in different Moroccan regions, who attended with high risk and/or symptoms of HIV/AIDS. The overall prevalence of positive HIV serology was 5.04% (4.67-5.44%). This rate was higher compared to blood donors which is 0.02%. From 1993 to 1998, the prevalence was around 4-5% (2.73-6.26%) then increased to 8.06% (6.89-9.36%) in 1999. Retrospective analysis of available epidemiological data have shown that the highest rate was observed in the South of Morocco with 12.23% (11.10-13.44%). Of the HIV positive cases, 72.22% of seropositives were infected heterosexually, 11.11% by intravenous drugs use, 7.41% by homosexuality, 4.63% by bisexuality and 4.63% and 0.62% by vertical transmission. The median age of infected persons was 33.3 years. Among documented HIV-positive individuals, 53.74% were aged 30-39 years, 21.43% were 20-29 years and 17.69% were 40 years or more. In this study, among HIV-positive patients 42.17% have loss of weight with fever and diarrhoea represent and 35.54% have loss of weight with fever, diarrhoea and opportunistic infections. The present work shows that the HIV infection increased significantly in 1999. Effective measures to control this trend should be implemented soon before the situation worsens.

Entities:  

Mesh:

Year:  2002        PMID: 12537738     DOI: 10.1258/095646202321020125

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  7 in total

Review 1.  HIV in the Middle East.

Authors:  Carla Makhlouf Obermeyer
Journal:  BMJ       Date:  2006-10-21

2.  HIV surveillance and epidemic profile in the Middle East and North Africa.

Authors:  Sherine Shawky; Cherif Soliman; Kassem M Kassak; Doaa Oraby; Danielle El-Khoury; Inoussa Kabore
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

3.  Acceptability of HIV/AIDS testing among pre-marital couples in Iran (2012).

Authors:  Jamshid Ayatollahi; Mohammad Ali Bagheri Nasab Sarab; Mohammad Reza Sharifi; Seyed Hossein Shahcheraghi
Journal:  Niger Med J       Date:  2014-07

4.  HIV-Care Outcome in Saudi Arabia; a Longitudinal Cohort.

Authors:  Maha A Al-Mozaini; Michael K Mansour; Abdullah A Al-Hokail; Magid A Mohmed; Munirah A Bin Daham; Hail M Al-Abdely; Husn H Frayha; Fahad A Al-Rabiah; Sami H Alhajjar; Salmaan Keshavjee; Chaker N Adra; Abdulrahman A Alrajhi
Journal:  J AIDS Clin Res       Date:  2014-11-08

5.  Estimation the Frequency of Human Immunodeficiency Virus among Male and Female Patients, Iran.

Authors:  Masoud Hajia; Ali Amirzargar; Mehdi Ghoreishi; Sohrab Sam
Journal:  Cell J       Date:  2011-12-22       Impact factor: 2.479

Review 6.  HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.

Authors:  Ghina R Mumtaz; Helen A Weiss; Sara L Thomas; Suzanne Riome; Hamidreza Setayesh; Gabriele Riedner; Iris Semini; Oussama Tawil; Francisca Ayodeji Akala; David Wilson; Laith J Abu-Raddad
Journal:  PLoS Med       Date:  2014-06-17       Impact factor: 11.069

7.  Estimation of seroprevalence of HIV, hepatitis B and C virus and syphilis among blood donors in the hospital of Aïoun, Mauritania.

Authors:  Boushab Mohamed Boushab; Ould Cheikh Melaïnine Mohamed Limame; Fall-Malick Fatim Zahra; Savadogo Mamoudou; Belizaire Marie Roseline Darnycka; Sow Mamadou Saliou
Journal:  Pan Afr Med J       Date:  2017-10-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.